American Power Group First Quarter Fiscal 2017 Results Conference Call Alert Update
Feb 10, 2017 14:00 pm UTC| Business
LYNNFIELD, Mass., Feb. 10, 2017 -- American Power Group Corporation (OTCQB:APGI) today announced it will host a conference call on Tuesday, February 14, 2017 at 10:00 AM Eastern to discuss the results for the three...
LifeSci Partners Launches LifeSci Public Relations
Feb 10, 2017 14:00 pm UTC| Business
Strategic and Tactical Capabilities to Ensure Audience EngagementHealthcare Public Relations Veteran Dr. Matt Middleman Appointed to Lead LifeSci Public RelationsUnique Synergies Realized by Integrating LifeSci’s PR and IR...
RegEd Named CE Quality Partner by CFP Board
Feb 10, 2017 14:00 pm UTC| Business
Raleigh, Feb. 10, 2017 -- RegEd has been named a “CFP Board CE Quality Partner” after successfully meeting criteria established by Certified Financial Planner Board of Standards Inc. (CFP Board). As a CE Quality...
Feb 10, 2017 13:55 pm UTC| Business
CHANDLER, Ariz., Feb. 10, 2017 -- Microchip Technology Incorporated (NASDAQ:MCHP) (“Microchip”) today announced the pricing of $1.8 billion aggregate principal amount of convertible senior subordinated notes due 2027...
NXP Semiconductors Announces Substantial Debt Reduction
Feb 10, 2017 13:30 pm UTC| Business
EINDHOVEN, The Netherlands, Feb. 10, 2017 -- NXP Semiconductors N.V. (NASDAQ:NXPI) through its subsidiaries NXP B.V. and NXP Funding LLC, delivered notice on February 7, 2017 that it will pre-pay (i) all of its...
Syntel to Announce Fourth Quarter and Full Year 2016 Results on Thursday, February 16, 2017
Feb 10, 2017 13:30 pm UTC| Business
TROY, Mich., Feb. 10, 2017 -- Syntel, Inc. (Nasdaq:SYNT), a leading global provider of integrated information technology and knowledge process services, will announce results for the Fourth Quarter and Full Year 2016,...
Ultragenyx to Present at Leerink Partners Global Healthcare Conference
Feb 10, 2017 13:30 pm UTC| Business
NOVATO, Calif., Feb. 10, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini...